Global Markets for Enzymes in Industrial Applications

The scope of this study encompasses the industrial enzymes, bio-technical, chemical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.

This report is an update to the previous report on industrial enzymes and explores the present and future strategies within the industrial enzymes market, which includes the detergent, technical, food and beverages, and animal feed sectors. The improvisation of the market, the setbacks and the needs of the market are discussed in this report. The comparisons, usage, and the advantages and disadvantages of types of enzymes are also portrayed in this report.

A detailed analysis of the enzymes industry structure has been conducted. Revenues are broken down by region. Sales figures are estimated for the five-year period from 2011 through 2016.

Applications for industrial enzymes are also discussed separately in the report, with emphasis of the use in technical enzymes and the food and beverages enzymes. The report also covers significant patents and their allotments in each category.

Industrial Enzymes Market

Published: March 2012
No. of Pages: 274
Price: Single User License: US$4850         Corporate User License: US$8500

REPORT HIGHLIGHTS
•    The global market for industrial enzymes was valued at $3.1 billion in 2009 and reached about $3.6 billion in 2010. The estimated market for 2011 is about $3.9 billion. BCC projects this market to grow at a compounded annual growth rate (CAGR) of 9.1% to reach $6 billion by 2016.
•    Food and beverage enzymes comprise the largest segment of the industrial enzymes industry with revenues of nearly $1.2 billion in 2010. This market is expected to reach $1.3 billion by 2011 and further it will grow to $2.1 billion by 2016, a CAGR of 10.4%.
•    The second-largest category is technical enzymes with revenues of about $1.1 billion in 2010 and nearly $1.2 billion in 2011. This market is further expected to grow to $1.7 billion by 2016, a CAGR of 8.2%.

Major points covered in Table of Contents of this report include:

Chapter- 1: INTRODUCTION
Chapter- 2: EXECUTIVE SUMMARY
Chapter- 3: OVERVIEW
Chapter- 4: CLASSIFICATION OF ENZYMES
Chapter- 5: REGULATORY ASPECTS
Chapter- 6: MARKET LEADERS AND THEIR PRODUCTS FOR INDUSTRIAL ENZYMES
Chapter- 7: NEW DEVELOPMENTS
Chapter- 8: GLOBAL MARKETS
Chapter- 9: MARKETS IN NORTH AMERICA
Chapter- 10: MARKETS IN EUROPE
Chapter- 11: MARKETS IN ASIA
Chapter- 12: EMERGING MARKETS/REST OF WORLD
Chapter- 13: PATENT ANALYSIS
Chapter- 14: CURRENT SITUATION
Chapter- 15: COMPANY PROFILESAB ENZYMES
Chapter- 16: APPENDIX I—ABBREVIATIONS
List of Tables
List of Figures

Browse reports related to Biotechnology @ http://www.reportsnreports.com/market-research/biotechnology/                  

Emerging Technologies: Stem cells

Emerging Technologies: Stem cells - Stem cell therapies will play an increasingly important role in the underserved field of regenerative medicine, as preclinical discoveries are translated into the clinical setting and product candidates slowly progress through a diverse pipeline.

Features and benefits
• A full stem cell pipeline by each therapeutic category from preclinical stage to registration candidates.
• Provides an insight into key players, recent deals and developments.

Browse All: Biotechnology Market Research Reports 

Highlights
Small and medium-sized research-led companies dominate the stem cells landscape, with a few large pharmaceutical companies beginning to invest in recent years. This sector is highly heterogeneous, consisting of different stem cells technology platforms, including embryonic and adult stem cells, applied in a wide range of therapy areas.

Geron’s recent divestment in the sector highlights the several technical challenges associated with the application of stem cells in certain therapy areas, in particular, the central nervous system.

Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Introduction to stem cells
Stem cell pipeline
Key players
Data sourcing

EXECUTIVE SUMMARY
Strategic scoping and focus
Datamonitor key findings
Recent updates

INTRODUCTION TO STEM CELLS
Key findings
An introduction to stem cells
Types of stem cells
Pipeline snapshotAlthough bone marrow stem cell transplant has been routinely used for over 4 decades to treat hematological malignancies, the potential of stem cells to regenerate or replace highly specialized damaged or lost tissues in serious degenerative disorders or debilitating diseases, such as myocardial infarction, spinal cord injuries, ischemic stroke, macular degeneration, diabetes, and multiple sclerosis, has yet to be realized. Key limitations that still need to be addressed include successful delivery, differentiation, engraftment, integration, vascularization, functionality, and long-term safety of the transplanted cells. In view of this, several companies are currently exploiting more easily achievable goals, using a more drug-like approach that utilizes stem cells to alter physiological conditions within the damaged tissue and that indirectly promotes repair and regulates inflammatory and immunomodulatory pathways.
SWOT analysis
Strengths
Opportunities
Weaknesses
Threats

STEM CELL PIPELINE
Key findings
Stem cell pipeline overview
Cardiovascular
Central nervous system
Ophthalmology
Endocrine and metabolic disorders
Immunology and inflammation
Musculoskeletal
Other indications

THE KEY PLAYERS
Overview
Mesoblast
Osiris Therapeutics
Athersys
Gamida Cell
Cytori Therapeutics
Geron

APPENDIX
References
Datamonitor research
Journal papers
Exchange rates